Maria Gaczynska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Gaczynska has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
- Pawel A. Osmulski
University of Texas Health Science Center at San Antonio
26 shared publications - Chun-Liang Chen
Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas
4 shared publications - Elżbieta Jankowska
Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland
3 shared publications - Michael H. Glickman
Faculty of Biology, Israel Institute of Technolog—Technion, Haifa, Israel
3 shared publications Nameer B. Kirma
Department of Molecular Medicine, University of Texas Health Science Center, San Antonio, USA
3 shared publications- Tim Hui-Ming Huang
Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
3 shared publications
Latest Publications
- Open Access
Strategies of mechanical adaptations of circulating tumor cells and properties of their cellular microenvironment have predictive and prognostic biomarker value
Mechanically demanding conditions in the blood circulation damage and kill majority of tumor-shed circulating tumor cells (CTCs). Mechanical fitness: a set of mechanical properties detected with atomic force spectroscopy based force spectrometry supports survival of CTCs. We propose that live CTCs isolated from peripheral blood of prostate cancer patients represent distinct strategies of fitness promoting mechanical adaptations to the fluid shear stress. Some of the cells mimicked properties of erythrocytes (high stiffness) or leukocytes (high deformability). The clustering strategy characterized by exceptionally high adhesion is ingenious to CTCs and not found in blood cells. The abundance of CTCs with elevated adhesion has a predictive value for prostate cancer patients starting 1 st round of androgen deprivation therapy. Moreover, a “high adhesion score” based on individual cells’ or average patient-specific adhesion is instrumental to stratify recurrent patients that underwent diagnostic imaging by PSMA-PET/CT and clarify inconclusive PSMA scan results. Including contribution of erythrocyte-like strategy broadened the predictive power of CTC mechanophenotyping. Improved biomarking opportunities to predict early castration resistances were noted when the composition of CTC microenvironment was included alongside the mechanical properties. We demonstrated previously that the CTC microenvironment is formed by large cells co-purifying by microfiltration of the blood of cancer patients. Analysis of the association of particular components of CTC microenvironment with the clustering strategy led to pointing at highly adhesive CTC-EMT. However, in the advanced patients adhesiveness of CTC-EMT was surpassed by tumor hybrid cells (THCs), a distinctive kind of invasive species formed by incomplete phagocytosis of CTCs by macrophages. THCs changed their mechanical phenotype and strategy preference with disease progression pointing at the dynamic nature of adaptations of tumor-shed cells to circulation conditions.
Open AccessStrategies of mechanical adaptations of circulating tumor cells and properties of their cellular microenvironment have predictive and prognostic biomarker value
Mechanically demanding conditions in the blood circulation damage and kill majority of tumor-shed circulating tumor cells (CTCs). Mechanical fitness: a set of mechanical properties detected with atomic force spectroscopy based force spectrometry supports survival of CTCs. We propose that live CTCs isolated from peripheral blood of prostate cancer patients represent distinct strategies of fitness promoting mechanical adaptations to the fluid shear stress. Some of the cells mimicked properties of erythrocytes (high stiffness) or leukocytes (high deformability). The clustering strategy characterized by exceptionally high adhesion is ingenious to CTCs and not found in blood cells. The abundance of CTCs with elevated adhesion has a predictive value for prostate cancer patients starting 1 st round of androgen deprivation therapy. Moreover, a “high adhesion score” based on individual cells’ or average patient-specific adhesion is instrumental to stratify recurrent patients that underwent diagnostic imaging by PSMA-PET/CT and clarify inconclusive PSMA scan results. Including contribution of erythrocyte-like strategy broadened the predictive power of CTC mechanophenotyping. Improved biomarking opportunities to predict early castration resistances were noted when the composition of CTC microenvironment was included alongside the mechanical properties. We demonstrated previously that the CTC microenvironment is formed by large cells co-purifying by microfiltration of the blood of cancer patients. Analysis of the association of particular components of CTC microenvironment with the clustering strategy led to pointing at highly adhesive CTC-EMT. However, in the advanced patients adhesiveness of CTC-EMT was surpassed by tumor hybrid cells (THCs), a distinctive kind of invasive species formed by incomplete phagocytosis of CTCs by macrophages. THCs changed their mechanical phenotype and strategy preference with disease progression pointing at the dynamic nature of adaptations of tumor-shed cells to circulation conditions.
- Open Access
Multivalent Adhesive Probe Atomic Force Microscopy (MAPA) for accessing dispersive adhesion of cells and biosurfaces
Adhesion of cells is the key factor determining functioning of multicellular organisms. Viscoelastic properties of cells can be studied by multiple methods. However, attractiveness of cells or extracellular matrix without the elastic component (dispersive adhesion) is not accessible. We present an extension of force spectrometry technology: the Multivalent Adhesive Probe Atomic Force Microscopy (MAPA) that delivers dispersive adhesion maps of live cells and biosurfaces, and identifies differences unresolved by viscoelastic probing.
Open AccessMultivalent Adhesive Probe Atomic Force Microscopy (MAPA) for accessing dispersive adhesion of cells and biosurfaces
Adhesion of cells is the key factor determining functioning of multicellular organisms. Viscoelastic properties of cells can be studied by multiple methods. However, attractiveness of cells or extracellular matrix without the elastic component (dispersive adhesion) is not accessible. We present an extension of force spectrometry technology: the Multivalent Adhesive Probe Atomic Force Microscopy (MAPA) that delivers dispersive adhesion maps of live cells and biosurfaces, and identifies differences unresolved by viscoelastic probing.
- 3 June 2026
- Published by Springer Nature
- Vol. 2999, 127-136
Model Circulating Tumor Cells Induced by Mechanical Stress
Circulating tumor cells (CTCs) display a range of specific mechanical properties that set them apart from tumor-residing cells. CTCs face a series of mechanobiology-related challenges: they need to break from the tumor, intravasate, withstand fluid shear stress (FSS) in circulation and then attach to the vessel wall for extravasation. Established carcinoma cell lines are adherent and grow on the surface of cell culture dishes. Such cells may represent tumor residents or advanced colonization of the metastatic niche; however, they are not adequate models of CTCs. Here, we describe the generation of “model CTCs” by subjecting carcinoma cell lines to circulation-imitating FSS in a microfluidic system. Such cells can be characterized by analytical methods of choice, including atomic force microscopy (AFM) based nanomechanical phenotyping. Indeed, model CTCs display nanomechanical properties resembling patient-isolated CTCs and are well suited for studies on mechanotransduction.
- 3 June 2026
- Published by Springer Nature
- Vol. 2999, 127-136
Model Circulating Tumor Cells Induced by Mechanical Stress
Circulating tumor cells (CTCs) display a range of specific mechanical properties that set them apart from tumor-residing cells. CTCs face a series of mechanobiology-related challenges: they need to break from the tumor, intravasate, withstand fluid shear stress (FSS) in circulation and then attach to the vessel wall for extravasation. Established carcinoma cell lines are adherent and grow on the surface of cell culture dishes. Such cells may represent tumor residents or advanced colonization of the metastatic niche; however, they are not adequate models of CTCs. Here, we describe the generation of “model CTCs” by subjecting carcinoma cell lines to circulation-imitating FSS in a microfluidic system. Such cells can be characterized by analytical methods of choice, including atomic force microscopy (AFM) based nanomechanical phenotyping. Indeed, model CTCs display nanomechanical properties resembling patient-isolated CTCs and are well suited for studies on mechanotransduction.
- 22 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6749) , 881-888
CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade
Antagonistic activities of the 53BP1 axis and the tumor suppressor BRCA1-BARD1 determine whether DNA double-strand breaks (DSBs) are repaired by end joining or homologous recombination. We show that the CTC1-STN1-TEN1 (CST) complex, a central 53BP1 axis component, suppresses DNA end resection by EXO1 and the BLM-DNA2 helicase-nuclease complex but acts by distinct mechanisms in restricting these entities. Whereas BRCA1-BARD1 alleviates the CST-imposed EXO1 blockade, it has little effect on BLM-DNA2 restriction. CST mutants impaired for DNA binding or BLM–EXO1 interaction exhibit a hyper-resection phenotype and render BRCA1-deficient cells resistant to poly(ADP–ribose) polymerase (PARP) inhibitors. Our findings mechanistically define the crucial role of CST in DNA DSB repair pathway choice and have implications for understanding cancer therapy resistance stemming from dysfunction of the 53BP1 axis.
- 22 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6749) , 881-888
CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade
Antagonistic activities of the 53BP1 axis and the tumor suppressor BRCA1-BARD1 determine whether DNA double-strand breaks (DSBs) are repaired by end joining or homologous recombination. We show that the CTC1-STN1-TEN1 (CST) complex, a central 53BP1 axis component, suppresses DNA end resection by EXO1 and the BLM-DNA2 helicase-nuclease complex but acts by distinct mechanisms in restricting these entities. Whereas BRCA1-BARD1 alleviates the CST-imposed EXO1 blockade, it has little effect on BLM-DNA2 restriction. CST mutants impaired for DNA binding or BLM–EXO1 interaction exhibit a hyper-resection phenotype and render BRCA1-deficient cells resistant to poly(ADP–ribose) polymerase (PARP) inhibitors. Our findings mechanistically define the crucial role of CST in DNA DSB repair pathway choice and have implications for understanding cancer therapy resistance stemming from dysfunction of the 53BP1 axis.
- Open Access
- 24 June 2024
- Published by Elsevier in Cancer Letters
- Vol. 597, 217063
Targeting S6K/NFκB/SQSTM1/Polθ signaling to suppress radiation resistance in prostate cancer
- 24 June 2024
- Published by Elsevier in Cancer Letters
- Vol. 597, 217063
Open AccessTargeting S6K/NFκB/SQSTM1/Polθ signaling to suppress radiation resistance in prostate cancer
- Open Access
- 17 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Phagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant dissemination
While macrophage phagocytosis is an immune defense mechanism against invading cellular organisms, cancer cells expressing the CD47 ligand send forward signals to repel this engulfment. Here we report that the reverse signaling using CD47 as a receptor additionally enhances a pro-survival function of prostate cancer cells under phagocytic attack. Although low CD47-expressing cancer cells still allow phagocytosis, the reverse signaling delays the process, leading to incomplete digestion of the entrapped cells and subsequent tumor hybrid cell (THC) formation. Viable THCs acquire c-Myc from parental cancer cells to upregulate both M1- and M2-like macrophage polarization genes. Consequently, THCs imitating dual macrophage features can confound immunosurveillance, gaining survival advantage in the host. Furthermore, these cells intrinsically express low levels of androgen receptor and its targets, resembling an adenocarcinoma-immune subtype of metastatic castration-resistant prostate cancer. Therefore, phagocytosis-generated THCs may represent a potential target for treating the disease.
- 17 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Open AccessPhagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant dissemination
While macrophage phagocytosis is an immune defense mechanism against invading cellular organisms, cancer cells expressing the CD47 ligand send forward signals to repel this engulfment. Here we report that the reverse signaling using CD47 as a receptor additionally enhances a pro-survival function of prostate cancer cells under phagocytic attack. Although low CD47-expressing cancer cells still allow phagocytosis, the reverse signaling delays the process, leading to incomplete digestion of the entrapped cells and subsequent tumor hybrid cell (THC) formation. Viable THCs acquire c-Myc from parental cancer cells to upregulate both M1- and M2-like macrophage polarization genes. Consequently, THCs imitating dual macrophage features can confound immunosurveillance, gaining survival advantage in the host. Furthermore, these cells intrinsically express low levels of androgen receptor and its targets, resembling an adenocarcinoma-immune subtype of metastatic castration-resistant prostate cancer. Therefore, phagocytosis-generated THCs may represent a potential target for treating the disease.
- Open Access
- 16 June 2023
- Published by MDPI AG in Preprints.org
Ex Vivo Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine
Lung cancer is the leading cause of global cancer-related mortality resulting in ~1.8 million deaths annually. Systemic, molecular targeted, and immune therapies have provided significant improvements of survival outcomes for patients. However, drug resistance usually arises and there is an urgent need for novel therapy screening and personalized medicine. 3D patient-derived organoid (PDO) models have emerged as a more effective and efficient alternative for ex vivo drug screening than 2D cell culture and patient-derived xenograft (PDX) models. In this review, we performed an extensive search of lung cancer PDO-based ex vivo drug screening studies. Lung cancer PDOs were successfully established from fresh or biobanked sections/biopsy of lung tumors, PDXs, and pleural affusion. PDOs were subject to ex vivo drug screening with chemotherapy, targeted therapy and immune therapy agents. PDOs mainly recapitulated the genomic alterations, transcriptomic landscape and drug sensitivity of primary tumors. Although sample sizes of the previous studies were limited and some technical challenges remained, PDOs showed promise to screen novel therapy drugs. With the technical advance of high throughput, tumor-on-chip, combined microenvironment, and air-liquid interface (ALI), the drug screening using PDOs would serve better for precision care of lung cancer patients.
- 16 June 2023
- Published by MDPI AG in Preprints.org
Open AccessEx Vivo Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine
Lung cancer is the leading cause of global cancer-related mortality resulting in ~1.8 million deaths annually. Systemic, molecular targeted, and immune therapies have provided significant improvements of survival outcomes for patients. However, drug resistance usually arises and there is an urgent need for novel therapy screening and personalized medicine. 3D patient-derived organoid (PDO) models have emerged as a more effective and efficient alternative for ex vivo drug screening than 2D cell culture and patient-derived xenograft (PDX) models. In this review, we performed an extensive search of lung cancer PDO-based ex vivo drug screening studies. Lung cancer PDOs were successfully established from fresh or biobanked sections/biopsy of lung tumors, PDXs, and pleural affusion. PDOs were subject to ex vivo drug screening with chemotherapy, targeted therapy and immune therapy agents. PDOs mainly recapitulated the genomic alterations, transcriptomic landscape and drug sensitivity of primary tumors. Although sample sizes of the previous studies were limited and some technical challenges remained, PDOs showed promise to screen novel therapy drugs. With the technical advance of high throughput, tumor-on-chip, combined microenvironment, and air-liquid interface (ALI), the drug screening using PDOs would serve better for precision care of lung cancer patients.
- Open Access
- 25 April 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy
Vascular mechanisms of Alzheimer’s disease (AD) may constitute a therapeutically addressable biological pathway underlying dementia. We previously demonstrated that soluble pathogenic forms of tau (tau oligomers) accumulate in brain microvasculature of AD and other tauopathies, including prominently in microvascular endothelial cells. Here we show that soluble pathogenic tau accumulates in brain microvascular endothelial cells of P301S(PS19) mice modeling tauopathy and drives AD-like brain microvascular deficits. Microvascular impairments in P301S(PS19) mice were partially negated by selective removal of pathogenic soluble tau aggregates from brain. We found that similar to trans-neuronal transmission of pathogenic forms of tau, soluble tau aggregates are internalized by brain microvascular endothelial cells in a heparin-sensitive manner and induce microtubule destabilization, block endothelial nitric oxide synthase (eNOS) activation, and potently induce endothelial cell senescence that was recapitulated in vivo in microvasculature of P301S(PS19) mice. Our studies suggest that soluble pathogenic tau aggregates mediate AD-like brain microvascular deficits in a mouse model of tauopathy, which may arise from endothelial cell senescence and eNOS dysfunction triggered by internalization of soluble tau aggregates.
- 25 April 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Open AccessSoluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy
Vascular mechanisms of Alzheimer’s disease (AD) may constitute a therapeutically addressable biological pathway underlying dementia. We previously demonstrated that soluble pathogenic forms of tau (tau oligomers) accumulate in brain microvasculature of AD and other tauopathies, including prominently in microvascular endothelial cells. Here we show that soluble pathogenic tau accumulates in brain microvascular endothelial cells of P301S(PS19) mice modeling tauopathy and drives AD-like brain microvascular deficits. Microvascular impairments in P301S(PS19) mice were partially negated by selective removal of pathogenic soluble tau aggregates from brain. We found that similar to trans-neuronal transmission of pathogenic forms of tau, soluble tau aggregates are internalized by brain microvascular endothelial cells in a heparin-sensitive manner and induce microtubule destabilization, block endothelial nitric oxide synthase (eNOS) activation, and potently induce endothelial cell senescence that was recapitulated in vivo in microvasculature of P301S(PS19) mice. Our studies suggest that soluble pathogenic tau aggregates mediate AD-like brain microvascular deficits in a mouse model of tauopathy, which may arise from endothelial cell senescence and eNOS dysfunction triggered by internalization of soluble tau aggregates.
- Open Access
- 20 April 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (4) , 704
Electronic Circular Dichroism Detects Conformational Changes Associated with Proteasome Gating Confirmed Using AFM Imaging
Many chronic diseases, including cancer and neurodegeneration, are linked to proteasome dysregulation. Proteasome activity, essential for maintaining proteostasis in a cell, is controlled by the gating mechanism and its underlying conformational transitions. Thus, developing effective methods to detect gate-related specific proteasome conformations could be a significant contribution to rational drug design. Since the structural analysis suggests that gate opening is associated with a decrease in the content of α-helices and β-sheets and an increase in random coil structures, we decided to explore the application of electronic circular dichroism (ECD) in the UV region to monitor the proteasome gating. A comparison of ECD spectra of wild type yeast 20S proteasome (predominantly closed) and an open-gate mutant (α3ΔN) revealed an increased intensity in the ECD band at 220 nm, which suggests increased contents of random coil and β-turn structures. This observation was further supported by evaluating ECD spectra of human 20S treated with low concentration of SDS, known as a gate-opening reagent. Next, to evaluate the power of ECD to probe a ligand-induced gate status, we treated the proteasome with H2T4, a tetracationic porphyrin that we showed previously to induce large-scale protein conformational changes upon binding to h20S. H2T4 caused a significant increase in the ECD band at 220 nm, interpreted as an induced opening of the 20S gate. In parallel, we imaged the gate-harboring alpha ring of the 20S with AFM, a technique that we used previously to visualize the predominantly closed gate in latent human or yeast 20S and the open gate in α3ΔN mutant. The results were convergent with the ECD data and showed a marked decrease in the content of closed-gate conformation in the H2T4-treated h20S. Our findings provide compelling support for the use of ECD measurements to conveniently monitor proteasome conformational changes related to gating phenomena. We predict that the observed association of spectroscopic and structural results will help with efficient design and characterization of exogenous proteasome regulators.
- 20 April 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (4) , 704
Open AccessElectronic Circular Dichroism Detects Conformational Changes Associated with Proteasome Gating Confirmed Using AFM Imaging
Many chronic diseases, including cancer and neurodegeneration, are linked to proteasome dysregulation. Proteasome activity, essential for maintaining proteostasis in a cell, is controlled by the gating mechanism and its underlying conformational transitions. Thus, developing effective methods to detect gate-related specific proteasome conformations could be a significant contribution to rational drug design. Since the structural analysis suggests that gate opening is associated with a decrease in the content of α-helices and β-sheets and an increase in random coil structures, we decided to explore the application of electronic circular dichroism (ECD) in the UV region to monitor the proteasome gating. A comparison of ECD spectra of wild type yeast 20S proteasome (predominantly closed) and an open-gate mutant (α3ΔN) revealed an increased intensity in the ECD band at 220 nm, which suggests increased contents of random coil and β-turn structures. This observation was further supported by evaluating ECD spectra of human 20S treated with low concentration of SDS, known as a gate-opening reagent. Next, to evaluate the power of ECD to probe a ligand-induced gate status, we treated the proteasome with H2T4, a tetracationic porphyrin that we showed previously to induce large-scale protein conformational changes upon binding to h20S. H2T4 caused a significant increase in the ECD band at 220 nm, interpreted as an induced opening of the 20S gate. In parallel, we imaged the gate-harboring alpha ring of the 20S with AFM, a technique that we used previously to visualize the predominantly closed gate in latent human or yeast 20S and the open gate in α3ΔN mutant. The results were convergent with the ECD data and showed a marked decrease in the content of closed-gate conformation in the H2T4-treated h20S. Our findings provide compelling support for the use of ECD measurements to conveniently monitor proteasome conformational changes related to gating phenomena. We predict that the observed association of spectroscopic and structural results will help with efficient design and characterization of exogenous proteasome regulators.
- Open Access
- 5 March 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (3) , 480
A Role for the Proteasome Alpha2 Subunit N-Tail in Substrate Processing
The proteolytic active sites of the 26S proteasome are sequestered within the catalytic chamber of its 20S core particle (CP). Access to this chamber is through a narrow channel defined by the seven outer α subunits. In the resting state, the N-termini of neighboring α subunits form a gate blocking access to the channel. The attachment of the activators or regulatory particles rearranges the blocking α subunit N-termini facilitating the entry of substrates. By truncating or mutating each of the participating α N-termini, we report that whereas only a few N-termini are important for maintaining the closed gate, all seven N-termini participate in the open gate. Specifically, the open state is stabilized by a hydrogen bond between an invariant tyrosine (Y) in each subunit with a conserved aspartate (D) in its counterclockwise neighbor. The lone exception is the α1–α2 pair leaving a gap in the ring circumference. The third residue (X) of this YD(X) motif aligns with the open channel. Phenylalanine at this position in the α2 subunit comes in direct contact with the translocating substrate. Consequently, deletion of the α2 N-terminal tail attenuates proteolysis despite the appearance of an open gate state. In summary, the interlacing N-terminal YD(X) motifs regulate both the gating and translocation of the substrate.
- 5 March 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (3) , 480
Open AccessA Role for the Proteasome Alpha2 Subunit N-Tail in Substrate Processing
The proteolytic active sites of the 26S proteasome are sequestered within the catalytic chamber of its 20S core particle (CP). Access to this chamber is through a narrow channel defined by the seven outer α subunits. In the resting state, the N-termini of neighboring α subunits form a gate blocking access to the channel. The attachment of the activators or regulatory particles rearranges the blocking α subunit N-termini facilitating the entry of substrates. By truncating or mutating each of the participating α N-termini, we report that whereas only a few N-termini are important for maintaining the closed gate, all seven N-termini participate in the open gate. Specifically, the open state is stabilized by a hydrogen bond between an invariant tyrosine (Y) in each subunit with a conserved aspartate (D) in its counterclockwise neighbor. The lone exception is the α1–α2 pair leaving a gap in the ring circumference. The third residue (X) of this YD(X) motif aligns with the open channel. Phenylalanine at this position in the α2 subunit comes in direct contact with the translocating substrate. Consequently, deletion of the α2 N-terminal tail attenuates proteolysis despite the appearance of an open gate state. In summary, the interlacing N-terminal YD(X) motifs regulate both the gating and translocation of the substrate.